CL
Colgate-Palmolive Company
NYSE: CL · CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS
$89.45
+0.07% today
Updated 2026-06-12
Market cap
$70.63B
P/E ratio
34.21
P/S ratio
3.40x
EPS (TTM)
$2.58
Dividend yield
2.35%
52W range
$74 – $99
Volume
5.5M
Colgate-Palmolive Company (CL) Insider transactions
Net insider activity
Net buying (481,133 shares)
Buy transactions
58
Sell transactions
42
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | MALCOLM, GREGORY | EVP and Controller | Sale | 2,300 | $88.44 | $203412.00 |
| 2026-05-11 | NORRINGTON, LORRIE M | Director | Buy | 2,424 | — | — |
| 2026-05-11 | NORRINGTON, LORRIE M | Director | Buy | 2,075 | — | — |
| 2026-05-11 | NEWMAN, BRIAN | Director | Buy | 2,424 | — | — |
| 2026-05-11 | NEWMAN, BRIAN | Director | Buy | 2,075 | — | — |
| 2026-05-11 | NELSON, KIMBERLY A | Director | Buy | 2,424 | — | — |
| 2026-05-11 | NELSON, KIMBERLY A | Director | Buy | 2,075 | — | — |
| 2026-05-11 | HUNDMEJEAN, MARTINA | Director | Buy | 2,424 | — | — |
| 2026-05-11 | HUNDMEJEAN, MARTINA | Director | Buy | 2,075 | — | — |
| 2026-05-11 | HARRIS, C MARTIN | Director | Buy | 2,424 | — | — |
| 2026-05-11 | HARRIS, C MARTIN | Director | Buy | 1,556 | — | — |
| 2026-05-11 | EDWARDS, LISA | Director | Buy | 2,424 | — | — |
| 2026-05-11 | EDWARDS, LISA | Director | Buy | 2,075 | — | — |
| 2026-05-11 | CAHILL, JOHN T | Director | Buy | 2,424 | — | — |
| 2026-05-11 | CAHILL, JOHN T | Director | Buy | 2,075 | — | — |
| 2026-05-11 | BOERNER, CHRISTOPHER S. | Director | Buy | 2,020 | — | — |
| 2026-05-11 | BOERNER, CHRISTOPHER S. | Director | Buy | 1,383 | — | — |
| 2026-05-11 | BILBREY, JOHN P | Director | Buy | 2,424 | — | — |
| 2026-05-11 | BILBREY, JOHN P | Director | Buy | 2,075 | — | — |
| 2026-05-07 | MASSEY, SALLY | Chief People Officer | Sale | 8,599 | $87.41 | $751632.57 |
| 2026-04-01 | NORRINGTON, LORRIE M | Director | Buy | 294 | $89.05 | $26180.70 |
| 2026-04-01 | NEWMAN, BRIAN | Director | Buy | 210 | $89.05 | $18700.50 |
| 2026-04-01 | BILBREY, JOHN P | Director | Buy | 266 | $89.05 | $23687.30 |
| 2026-02-23 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Buy | 136,710 | — | — |
| 2026-02-23 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Sale | 68,252 | $97.10 | $6.63M |
| 2026-02-23 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Buy | 25,742 | — | — |
| 2026-02-23 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 13,081 | $97.10 | $1.27M |
| 2026-02-23 | SUTULA, STANLEY J III | Chief Financial Officer | Buy | 38,678 | — | — |
| 2026-02-23 | SUTULA, STANLEY J III | Chief Financial Officer | Sale | 19,746 | $97.10 | $1.92M |
| 2026-02-23 | MASSEY, SALLY | Chief Human Resources Officer | Buy | 16,805 | — | — |
| 2026-02-23 | MASSEY, SALLY | Chief Human Resources Officer | Sale | 8,206 | $97.10 | $796802.60 |
| 2026-02-23 | MALCOLM, GREGORY | EVP and Controller | Buy | 6,268 | — | — |
| 2026-02-23 | MALCOLM, GREGORY | EVP and Controller | Sale | 2,260 | $97.10 | $219446.00 |
| 2026-02-23 | HAZLIN, JOHN | Chief Growth Officer | Buy | 12,803 | — | — |
| 2026-02-23 | HAZLIN, JOHN | Chief Growth Officer | Sale | 6,117 | $97.10 | $593960.70 |
| 2026-02-23 | DANIELS, JENNIFER | CLO and Secretary | Buy | 25,742 | — | — |
| 2026-02-23 | DANIELS, JENNIFER | CLO and Secretary | Sale | 12,351 | $97.10 | $1.20M |
| 2026-02-12 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 15,000 | — | — |
| 2026-02-12 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Buy | 15,000 | $76.41 | $1.15M |
| 2026-02-11 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 35,000 | — | — |
| 2026-02-11 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 35,000 | $94.61 | $3.31M |
| 2026-02-10 | HAZLIN, JOHN | Chief Growth Officer | Sale | 20,989 | — | — |
| 2026-02-10 | HAZLIN, JOHN | Chief Growth Officer | Buy | 20,989 | $76.41 | $1.60M |
| 2026-02-06 | MALCOLM, GREGORY | EVP and Controller | Sale | 12,747 | — | — |
| 2026-02-06 | MALCOLM, GREGORY | EVP and Controller | Buy | 12,747 | $76.41 | $973998.27 |
| 2026-02-05 | MASSEY, SALLY | Chief Human Resources Officer | Sale | 15,851 | — | — |
| 2026-02-05 | MASSEY, SALLY | Chief Human Resources Officer | Buy | 15,851 | $76.41 | $1.21M |
| 2026-02-04 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Sale | 45,568 | $93.91 | $4.28M |
| 2026-02-04 | SUTULA, STANLEY J III | Chief Financial Officer | Sale | 97,843 | — | — |
| 2026-02-04 | SUTULA, STANLEY J III | Chief Financial Officer | Buy | 97,843 | $81.78 | $8.00M |
| 2026-02-04 | DANIELS, JENNIFER | CLO and Secretary | Sale | 22,000 | — | — |
| 2026-02-04 | DANIELS, JENNIFER | CLO and Secretary | Sale | 22,000 | $94.34 | $2.08M |
| 2026-01-02 | NORRINGTON, LORRIE M | Director | Buy | 333 | $78.66 | $26193.78 |
| 2026-01-02 | NEWMAN, BRIAN | Director | Buy | 238 | $78.66 | $18721.08 |
| 2026-01-02 | BILBREY, JOHN P | Director | Buy | 301 | $78.66 | $23676.66 |
| 2025-12-03 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Sale | 1,307 | $78.20 | $102207.40 |
| 2025-12-03 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 221 | $78.20 | $17282.20 |
| 2025-12-03 | SUTULA, STANLEY J III | Chief Financial Officer | Sale | 385 | $78.20 | $30107.00 |
| 2025-12-03 | MALCOLM, GREGORY | EVP and Controller | Sale | 41 | $78.20 | $3206.20 |
| 2025-12-03 | HAZLIN, JOHN | Chief Growth Officer | Sale | 156 | $78.20 | $12199.20 |
| 2025-12-03 | DANIELS, JENNIFER | CLO and Secretary | Sale | 213 | $78.20 | $16656.60 |
| 2025-11-21 | MASSEY, SALLY | Chief Human Resources Officer | Sale | 1,237 | $80.89 | $100060.93 |
| 2025-10-01 | NORRINGTON, LORRIE M | Director | Buy | 319 | $82.13 | $26199.47 |
| 2025-10-01 | NEWMAN, BRIAN | Director | Buy | 228 | $82.13 | $18725.64 |
| 2025-10-01 | BILBREY, JOHN P | Director | Buy | 289 | $82.13 | $23735.57 |
| 2025-09-13 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Sale | 4,777 | $83.28 | $397828.56 |
| 2025-09-13 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 900 | $83.28 | $74952.00 |
| 2025-09-13 | SUTULA, STANLEY J III | Chief Financial Officer | Sale | 1,352 | $83.28 | $112594.56 |
| 2025-09-13 | PARAMESWARAN, PRABHA | Vice Chair | Sale | 979 | $83.28 | $81531.12 |
| 2025-09-13 | MASSEY, SALLY | Chief Human Resources Officer | Sale | 669 | $83.28 | $55714.32 |
| 2025-09-13 | MALCOLM, GREGORY | EVP and Controller | Sale | 152 | $83.28 | $12658.56 |
| 2025-09-13 | HAZLIN, JOHN | Chief Growth Officer | Sale | 449 | $83.28 | $37392.72 |
| 2025-09-13 | DANIELS, JENNIFER | CLO and Secretary | Sale | 900 | $83.28 | $74952.00 |
| 2025-09-12 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Sale | 2,972 | $83.28 | $247508.16 |
| 2025-09-12 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Sale | 521 | $83.28 | $43388.88 |
| 2025-09-12 | SUTULA, STANLEY J III | Chief Financial Officer | Sale | 784 | $83.28 | $65291.52 |
| 2025-09-12 | PARAMESWARAN, PRABHA | Vice Chair | Sale | 699 | $83.28 | $58212.72 |
| 2025-09-12 | MASSEY, SALLY | Chief Human Resources Officer | Sale | 447 | $83.28 | $37226.16 |
| 2025-09-12 | MALCOLM, GREGORY | EVP and Controller | Sale | 89 | $83.28 | $7411.92 |
| 2025-09-12 | HAZLIN, JOHN | Chief Growth Officer | Sale | 377 | $83.28 | $31396.56 |
| 2025-09-12 | DANIELS, JENNIFER | CLO and Secretary | Sale | 521 | $83.28 | $43388.88 |
| 2025-09-11 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Buy | 196,047 | — | — |
| 2025-09-11 | WALLACE, NOEL R. | Director, Chairman, President & CEO | Buy | 28,314 | — | — |
| 2025-09-11 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Buy | 32,949 | — | — |
| 2025-09-11 | TSOURAPAS, PANAGIOTIS | COO, Eur., APac, Afr Eur, Skin | Buy | 4,759 | — | — |
| 2025-09-11 | SUTULA, STANLEY J III | Chief Financial Officer | Buy | 57,661 | — | — |
| 2025-09-11 | SUTULA, STANLEY J III | Chief Financial Officer | Buy | 8,328 | — | — |
| 2025-09-11 | PARAMESWARAN, PRABHA | Vice Chair | Buy | 31,796 | — | — |
| 2025-09-11 | PARAMESWARAN, PRABHA | Vice Chair | Buy | 4,592 | — | — |
| 2025-09-11 | MASSEY, SALLY | Chief Human Resources Officer | Buy | 23,888 | — | — |
| 2025-09-11 | MASSEY, SALLY | Chief Human Resources Officer | Buy | 3,450 | — | — |
| 2025-09-11 | MALCOLM, GREGORY | EVP and Controller | Buy | 7,743 | — | — |
| 2025-09-11 | MALCOLM, GREGORY | EVP and Controller | Buy | 1,119 | — | — |
| 2025-09-11 | HAZLIN, JOHN | Chief Growth Officer | Buy | 28,007 | — | — |
| 2025-09-11 | HAZLIN, JOHN | Chief Growth Officer | Buy | 4,045 | — | — |
| 2025-09-11 | GRANT, SHANE | COO, Americas | Buy | 24,712 | — | — |
| 2025-09-11 | GRANT, SHANE | COO, Americas | Buy | 3,569 | — | — |
| 2025-09-11 | DANIELS, JENNIFER | CLO and Secretary | Buy | 31,796 | — | — |
| 2025-09-11 | DANIELS, JENNIFER | CLO and Secretary | Buy | 4,592 | — | — |
| 2025-07-01 | NORRINGTON, LORRIE M | Director | Buy | 292 | $89.91 | $26253.72 |
Frequently asked questions
Are CL insiders buying or selling?
Over the transactions on record, CL insiders have been net buyers, with about $24.91M in stock sold across 42 sales, against 15 open-market purchases.
Does insider selling at CL mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which CL insiders are selling the most?
Recent selling is concentrated in a few names. WALLACE, NOEL R. accounts for the largest share on record, with about $11.65M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.